|Title||Medical uncertainty and reproduction of the “normal”: Decision-making around testosterone therapy in transgender pregnancy|
|Authors||Pfeffer, C., Hines, S., Pearce, R., Riggs, D., Ruspini, E. and White, F.R.|
In this work, we draw upon in-depth interview and focus group data from a three-year international study of 70 trans people (residing across Australia, Canada, the European Union, United Kingdom, and the United States) about their intentions and experiences around pregnancy, as well as 22 health care providers (practicing across Australia, Canada, the European Union, the United Kingdom, and the United States) with self-identified experience working with trans patients and pregnancy along a diverse cross-section of specialty areas (e.g., psychotherapists, general practitioners, endocrinologists, midwives, lactation consultants, OBGYNs, fertility specialists). The central motivating questions guiding the present work are: 1) For trans people who are taking testosterone, what is the medical advice and guidance around stopping or pausing testosterone therapy to become pregnant, throughout pregnancy, and during the postpartum period (particularly in the context of chestfeeding/breastfeeding); 2) What is the evidence base in the medical empirical literature for this guidance; and 3) How do trans people respond to this guidance?
|Journal||SSM - Qualitative Research in Health|
File Access Level
Open (open metadata and files)
|Digital Object Identifier (DOI)||https://doi.org/10.1016/j.ssmqr.2023.100297|
|Published||09 Jun 2023|